News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Global equity indices traded near flat in the past hour with low volume and no clear direction.
  • US Treasury yields were little changed, leaving the 10-year yield around recent levels.
  • The dollar index remained steady, showing minimal movement against major currencies.
  • Brent and WTI crude prices showed only minor fluctuations and no clear trend in the last hour.
  • No major economic data releases or central bank remarks occurred in the past hour.
  • No new geopolitical or political developments emerged to move markets during the hour.

Latest Articles

Buying Breakthroughs: A Long Thesis on Anthropic’s Platform Potential

Buying Breakthroughs: A Long Thesis on Anthropic’s Platform Potential

Anthropic sits at the center of the high-value enterprise AI market with a safety-first LLM platform. With product-led enterprise traction, cloud partnerships, and a differentiated safety posture, a disciplined long can capture outsized upside around commercialization and liquidity events. This is a high-risk, high-reward trade: entry at $25.00, st…

Decent Holding Provides Operational Update: Senior Care Operation Centers Expand to Approximately 700 Locations

Decent Holding Provides Operational Update: Senior Care Operation Centers Expand to Approximately 700 Locations

Decent Holding Inc., a NASDAQ-listed company, announced significant operational expansion of its AI-powered senior care platform in China. The company's senior care operation centers have grown to about 700 locations, with an estimated 240,000 paid members. Management plans to continue refining service offerings and pricing while expanding communit…

Kinetic’s Global Partnerships Accelerate Fiber Expansion, Reduce Costs, Enhance Customer Experience via ‘QuickConnect’ technology

Kinetic’s Global Partnerships Accelerate Fiber Expansion, Reduce Costs, Enhance Customer Experience via ‘QuickConnect’ technology

Kinetic, a business unit of Uniti, announced a strategic partnership with STL Optical Connectivity NA to deploy advanced CONACT fiber cable assembly technology (QuickConnect) across its 18-state footprint. This plug-and-play fiber solution will speed up fiber construction, reduce deployment costs, improve build quality, and enhance customer experie…

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Gain Therapeutics presented positive 12-month open-label extension data from its Phase 1b study of rexaceract in Parkinson's disease patients. The data showed stabilization of motor scores (MDS-UPDRS Parts II and III) with no significant disease progression or safety concerns, supporting the drug’s disease-modifying potential. The company plans to …

Quantum X Labs Files for U.S. Patent to LayerQake, a Quantum Cybersecurity Technology Designed to Detect Rare and Anomalous Events

Quantum X Labs Files for U.S. Patent to LayerQake, a Quantum Cybersecurity Technology Designed to Detect Rare and Anomalous Events

Quantum X Labs Inc. announced that its subsidiary has filed a U.S. patent application for LayerQake, a quantum cybersecurity technology designed to detect and localize rare anomalous activities using advanced quantum stratified inference and Bayesian analysis. The technology targets high-dimensional data environments and has applications in defense…

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

Ernexa Therapeutics announced the appointment of Dr. Robert J. Spiegel to its Board of Directors, bringing significant oncology and clinical development expertise as the company focuses on advancing its lead cell therapy candidate ERNA-101 toward clinical trials. Encouraging preclinical data showed complete tumor clearance and 100% survival in ovar…

Alibaba's Silicon Pivot: A Practical Trade on an Infrastructure Re-Rate

Alibaba's Silicon Pivot: A Practical Trade on an Infrastructure Re-Rate

Alibaba is building custom silicon and AI infrastructure at scale. Cloud revenue is accelerating and adjusted EBITA is expanding, but heavy AI-related CapEx has turned free cash flow negative. This trade idea buys the re-rate potential while limiting downside via a clear stop. Entry $108.54, target $145.00, stop $96.00 — long term (180 trading days…

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

PolyPid Ltd. announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) for D-PLEX100, its lead product candidate for preventing post-abdominal surgical site infections. This validation confirms a complete application and initiates formal EMA review. Concurrently, the FDA has accepted D-PLEX100's …

Giftify’s CardCash Deploys AI-Powered Customer Service Tools to Cut Response Times by More Than 90%

Giftify’s CardCash Deploys AI-Powered Customer Service Tools to Cut Response Times by More Than 90%

Giftify, Inc., operator of CardCash.com and Restaurant.com, has deployed an AI-powered customer service system that has reduced average response times by more than 90% without increasing staffing costs. This innovation helps gather necessary information before inquiries reach human agents, improving efficiency. Operational changes, including better…

Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing

Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing

Definitive Healthcare, a US-based healthcare data and analytics provider, announced its membership in the Network Advertising Initiative (NAI) to reinforce its commitment to responsible data stewardship and strict privacy standards. This move enhances confidence among its healthcare advertising customers by ensuring compliance with complex federal …

Access Is Becoming Manufacturing’s Competitive Advantage, According to Xometry's 2027 U.S. Manufacturing Outlook

Access Is Becoming Manufacturing’s Competitive Advantage, According to Xometry's 2027 U.S. Manufacturing Outlook

Xometry released its 2027 U.S. Manufacturing Outlook report, emphasizing a shift in manufacturing competitive advantage from owning assets to having access to capacity, qualified suppliers, and AI-driven intelligence. Key trends include AI's upstream impact on manufacturability and costing, underutilized capacity in smaller manufacturers, the growi…

FingerMotion and BlueFlare Sign Binding Agreement to Acquire 20-Acre Site in Hanna, Alberta, Establishing Hanna Campus #1 for AI Inference Compute

FingerMotion and BlueFlare Sign Binding Agreement to Acquire 20-Acre Site in Hanna, Alberta, Establishing Hanna Campus #1 for AI Inference Compute

FingerMotion, Inc. (Nasdaq: FNGR) has entered into a binding agreement with BlueFlare Group Holdings Inc. to acquire a 20.2-acre site in Hanna, Alberta. The site, named Hanna Campus #1, will be developed into an AI inference compute campus powered by a combination of local grid electricity and behind-the-meter natural gas generation with a total ca…

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

AIM ImmunoTech Inc. highlights growing media attention and clinical progress in its development of Ampligen® (rintatolimod) for metastatic pancreatic cancer. The Phase 2 DURIPANC trial combining Ampligen with AstraZeneca's Imfinzi is advancing, with final Ampligen dosing completed and topline results anticipated in early 2027. Prior Named Patient P…

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics has submitted an application to the Centers for Medicare & Medicaid Services (CMS) requesting a permanent, product-specific HCPCS Level II J-code for its FDA-approved ophthalmic drug LYTENAVA, used in treating wet age-related macular degeneration (wet AMD). The move aims to facilitate reimbursement, streamline billing, and enha…

Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma

Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma

Legend Biotech announced the launch of its inaugural ELITE grant program aimed at supporting early-career healthcare professionals advancing research, education, and innovation in CAR-T cell therapy for multiple myeloma. This annual initiative seeks to encourage novel approaches with funding awards and promotes leadership in the cellular therapy fi…

Applied Materials and Besi Expand Strategic Partnership to Advance Next-Generation Packaging for AI Scaling

Applied Materials and Besi Expand Strategic Partnership to Advance Next-Generation Packaging for AI Scaling

Applied Materials and Besi have deepened their collaboration by Besi joining Applied's EPIC Center as an Innovation Partner. This partnership builds on their 2020 joint Hybrid Bonding Center of Excellence in Singapore and targets scaling advanced packaging technologies vital for AI infrastructure. The collaboration aims to develop next-generation 3…

Game Your Game to Participate in Maxim Growth Summit 2026 Conference

Game Your Game to Participate in Maxim Growth Summit 2026 Conference

Game Your Game, Inc., an AI-driven sports performance technology company listed on Nasdaq under ticker GYGY, announced that its Chairman and CEO, Soumya Das, will participate in the Maxim Growth Summit 2026 in New York. The company showcased its AI-powered GameGolf KZN platform, which integrates hardware and subscription software to enhance golf pe…